{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T14:52:01Z","timestamp":1787755921676,"version":"build-2784847793"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin J Gastroenterol"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1007\/s12328-019-01051-0","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T19:06:20Z","timestamp":1570734380000},"page":"308-315","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Localized biphasic malignant peritoneal mesothelioma presenting as a rectal tumor"],"prefix":"10.1007","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6157-2593","authenticated-orcid":false,"given":"Kohei","family":"Saisho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiro","family":"Anami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoichi","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Kusaba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsutomu","family":"Daa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nabeshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshito","family":"Akagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"1051_CR1","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1097\/CEJ.0b013e3282f0c0a2","volume":"17","author":"MJ Teta","year":"2008","unstructured":"Teta MJ, Mink PJ, Lau E, et al. US mesothelioma patterns 1973\u20132002: indicators of change and insights into background rates. Eur J Cancer Prev. 2008;17:525\u201334.","journal-title":"Eur J Cancer Prev"},{"key":"1051_CR2","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jso.21167","volume":"99","author":"D Rodr\u00edguez","year":"2009","unstructured":"Rodr\u00edguez D, Cheung MC, Housri N, et al. Malignant abdominal mesothelioma: defining the role of surgery. J Surg Oncol. 2009;99:51\u20137.","journal-title":"J Surg Oncol"},{"key":"1051_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1349-7006.2011.02165.x","volume":"103","author":"K Gemba","year":"2012","unstructured":"Gemba K, Fujimoto N, Kato K, et al. National survey of malignant mesothelioma and asbestos exposure in Japan. Cancer Sci. 2012;103:483\u201390.","journal-title":"Cancer Sci"},{"key":"1051_CR4","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1093\/annonc\/mdl345","volume":"18","author":"P Boffetta","year":"2007","unstructured":"Boffetta P. Epidemiology of peritoneal mesothelioma: a review. Ann Oncol. 2007;18:985\u201390.","journal-title":"Ann Oncol"},{"key":"1051_CR5","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1136\/oem.51.12.804","volume":"51","author":"R Spirtas","year":"1994","unstructured":"Spirtas R, Heineman EF, Bernstein L, et al. Malignant mesothelioma: attributable risk of asbestos exposure. Occup Environ Med. 1994;51:804\u201311.","journal-title":"Occup Environ Med"},{"key":"1051_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00384-014-2029-1","volume":"30","author":"S Cao","year":"2015","unstructured":"Cao S, Jin S, Cao J, et al. Advances in malignant peritoneal mesothelioma. Int J Colorectal Dis. 2015;30:1\u201310.","journal-title":"Int J Colorectal Dis"},{"key":"1051_CR7","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/S0046-8177(77)80067-1","volume":"8","author":"M Kannerstein","year":"1977","unstructured":"Kannerstein M, Churg J. Peritoneal mesothelioma. Hum Pathol. 1977;8:83\u201394.","journal-title":"Hum Pathol"},{"key":"1051_CR8","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4149\/neo_2014_053","volume":"61","author":"H Kaya","year":"2014","unstructured":"Kaya H, Sezg\u0131 C, Tanr\u0131kulu AC, et al. Prognostic factors influencing survival in 35 patients with malignant peritoneal mesothelioma. Neoplasma. 2014;61:433\u20138.","journal-title":"Neoplasma"},{"key":"1051_CR9","doi-asserted-by":"publisher","first-page":"2620","DOI":"10.1007\/s00330-003-1851-6","volume":"13","author":"M Kebapci","year":"2003","unstructured":"Kebapci M, Vardareli E, Adapinar B, et al. CT findings and serum ca 125 levels in malignant peritoneal mesothelioma: report of 11 new cases and review of the literature. Eur Radiol. 2003;13:2620\u20136.","journal-title":"Eur Radiol"},{"key":"1051_CR10","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1148\/rg.282075175","volume":"28","author":"AD Levy","year":"2008","unstructured":"Levy AD, Arn\u00e1iz J, Shaw JC, et al. From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation. Radiographics. 2008;28:583\u2013607.","journal-title":"Radiographics"},{"key":"1051_CR11","first-page":"1593","volume":"45","author":"S Shimoyama","year":"1998","unstructured":"Shimoyama S, Konish T, Kawahara M, et al. A rare case of primary malignant mesothelioma originating from the rectovaginal tissue. Hepatogastroenterology. 1998;45:1593\u20137.","journal-title":"Hepatogastroenterology"},{"key":"1051_CR12","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.gie.2009.09.014","volume":"71","author":"CC Chan","year":"2010","unstructured":"Chan CC, Isomoto H, Ohnita K, et al. Colonic invasion of malignant peritoneal mesothelioma. Gastrointest Endosc. 2010;71:397\u20138.","journal-title":"Gastrointest Endosc"},{"key":"1051_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1186\/1477-7819-12-112","volume":"12","author":"Y Takehara","year":"2014","unstructured":"Takehara Y, Endo S, Mori Y, et al. Malignant peritoneal mesothelioma with lymph node metastasis that originated in the transverse colon. World J Surg Oncol. 2014;12:112\u2013112.","journal-title":"World J Surg Oncol"},{"key":"1051_CR14","doi-asserted-by":"publisher","first-page":"e23","DOI":"10.14309\/crj.2018.23","volume":"5","author":"Z Field","year":"2018","unstructured":"Field Z, Zori A, Khullar V, et al. Malignant peritoneal mesothelioma presenting as mucinous ascites. ACG Case Rep J. 2018;5:e23\u2013e2323.","journal-title":"ACG Case Rep J"},{"key":"1051_CR15","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/S1055-3207(03)00045-0","volume":"12","author":"PH Sugarbaker","year":"2003","unstructured":"Sugarbaker PH, Welch LS, Mohamed F, et al. A review of peritoneal mesothelioma at the Washington Cancer Institute. Surg Oncol Clin N Am. 2003;12:605\u201321.","journal-title":"Surg Oncol Clin N Am"},{"key":"1051_CR16","doi-asserted-by":"publisher","first-page":"89","DOI":"10.5858\/arpa.2017-0124-RA","volume":"142","author":"AN Husain","year":"2018","unstructured":"Husain AN, Colby TV, Ord\u00f3\u00f1ez NG, et al. Guidelines for pathologic diagnosis of malignant mesothelioma 2017 update of the consensus statement from the International Mesothelioma Interest Group. Arch Pathol Lab Med. 2018;142:89\u2013108.","journal-title":"Arch Pathol Lab Med"},{"key":"1051_CR17","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1038\/modpathol.2015.65","volume":"28","author":"M Cigognetti","year":"2015","unstructured":"Cigognetti M, Lonardi S, Fisogni S, et al. BAP1 (BRCA1-associated protein 1) is a highly specific marker for differentiating mesothelioma from reactive mesothelial proliferations. Mod Pathol. 2015;28:1043\u201357.","journal-title":"Mod Pathol"},{"key":"1051_CR18","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1309\/AJCPP5R2ZJZKCLWN","volume":"135","author":"SE Monaco","year":"2011","unstructured":"Monaco SE, Shuai Y, Bansal M, et al. The diagnostic utility of p16 FISH and GLUT-1 immunohistochemical analysis in mesothelial proliferations. Am J Clin Pathol. 2011;135:619\u201327.","journal-title":"Am J Clin Pathol"},{"key":"1051_CR19","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.anndiagpath.2016.10.010","volume":"26","author":"DI Wu","year":"2017","unstructured":"Wu DI, Hiroshima K, Yusa T, et al. Usefulness of p16\/CDKN2A fluorescence in situ hybridization and BAP1 immunohistochemistry for the diagnosis of biphasic mesothelioma. Ann Diagn Pathol. 2017;26:31\u20137.","journal-title":"Ann Diagn Pathol"},{"key":"1051_CR20","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1002\/jso.21177","volume":"99","author":"TC Chua","year":"2009","unstructured":"Chua TC, Yan TD, Morris DL. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience. J Surg Oncol. 2009;99:109\u201313.","journal-title":"J Surg Oncol"},{"key":"1051_CR21","doi-asserted-by":"publisher","first-page":"6237","DOI":"10.1200\/JCO.2009.23.9640","volume":"27","author":"TD Yan","year":"2009","unstructured":"Yan TD, Deraco M, Baratti D, et al. Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for malignant peritoneal mesothelioma: multi-institutional experience. J Clin Oncol. 2009;27:6237\u201342.","journal-title":"J Clin Oncol"},{"key":"1051_CR22","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1016\/j.ejso.2006.03.009","volume":"32","author":"R Garcia Carbonero","year":"2006","unstructured":"Garcia Carbonero R, Paz Ares L. Systemic chemotherapy in the management of malignant peritoneal mesothelioma. Eur J Surg Oncol. 2006;32:676\u201381.","journal-title":"Eur J Surg Oncol"},{"key":"1051_CR23","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","volume":"82","author":"P Jacquet","year":"1996","unstructured":"Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res. 1996;82:359\u201374.","journal-title":"Cancer Treat Res"}],"container-title":["Clinical Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12328-019-01051-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12328-019-01051-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,8]],"date-time":"2020-10-08T23:30:01Z","timestamp":1602199801000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12328-019-01051-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["1051"],"URL":"https:\/\/doi.org\/10.1007\/s12328-019-01051-0","relation":{},"ISSN":["1865-7257","1865-7265"],"issn-type":[{"value":"1865-7257","type":"print"},{"value":"1865-7265","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,10]]},"assertion":[{"value":"10 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 October 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare that have no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"All procedure performed in studies involving human participants were in accordance with the ethical standards of the institutional research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was obtained from the patient\u2019s family in this case report because the patient was dead.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}